Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                

New isoflavan from Erythrina livingstoniana

Natural Product Research

New Isoflavan from Erythrina Livingstoniana Nayang A. Kgakatsi,a,c Runner R.T. Majinda,a Ishmael B. Masesanea, Mutshinyalo S. Nwamadi,b Taye B. Demissie,a Japheth O. Ombito,a Irene Gobed a Department of Chemistry, University of Botswana, Private Bag UB 0022, Gaborone, Botswana b Spectrum, University of Johannesburg, P.O Box 524, Auckland Park, 2006. Cnr Kingsway & University Roads, Auckland Park, Johannesburg, 2092, South Africa c d Boitekanelo College, P.O Box 203156, Old Naledi Kiosk, Gaborone, Botswana Department of Medical Laboratory Science, University of Botswana, Private Bag UB 0022, Gaborone, Botswana Correspondence: Nayang A. Kgakatsi; Email: kgakatsina@gmail.com; nkgakatsi@boitekanelo.ac.bw Abstract Chemical investigation of the root wood of Erythrina livingstoniana led to the isolation of one previously undescribed isoflavan (3S,3″R)-7-hydroxy-2′-methoxy-[3″-hydroxy-2″,2″dimethylpyrano (3′,4′)] isoflavan (1), together with eleven known compounds (2-12). The structure of compound 1 was elucidated on the basis of extensive spectroscopic and spectrometric analyses (1D and 2D-NMR and APCI-HRMS), with absolute configurations established by comparison of experimental and DFT calculated ECD data. The assignment of the absolute configurations of C-3 and C-3″ of compounds 2 and 3, respectively, were reported for the first time. Compounds 1 - 4 were evaluated for their antibacterial activities in vitro against E. coli ATCC 25922 and S. aureus ATCC 25923. Compound 1 exhibited moderate antibacterial activity with MIC value of 0.063 mg/mL against the clinically relevant risk-group 2 (RG-2) bacterium S. aureus. Contents 1. Tables Lists Table S1. 1H (500 MHz) and 13C NMR (125 MHz) spectroscopic data of compound 1 Table S2. 1H (500 MHz) and 13C NMR (125 MHz) spectroscopic data of compound 2 Table S3. 1H (500 MHz) and 13C NMR (125 MHz) spectroscopic data of compound 3 Table S4. Antibacterial activities of compounds 1 – 4 2. Figure Legends Figure S1. APCI-HRMS spectrum of compound 1 Figure S2. 1H NMR (500 MHz, Acetone-d6) spectrum of compound 1 Figure S3. 13C NMR (125 MHz, Acetone-d6) spectrum of compound 1 Figure S4. DEPT 135 NMR (125 MHz, Acetone-d6) spectrum of compound 1 Figure S5. 1H–1H COSY (500 MHz, Acetone-d6) spectrum of compound 1 Figure S6. HMQC spectrum of compound 1 in Acetone-d6 Figure S7. HMBC spectrum of compound 1 in Acetone-d6 Figure S8. NOESY spectrum of compound 1 in Acetone-d6 Figure S9. Key 1H–1H COSY, 1H–1H NOESY, and HMBC correlations of compound 1 Figure S10. Experimental and calculated electronic circular dichroism (ECD) spectra of compound 1 Figure S11. APCI-HRMS spectrum of compound 1 Figure S12. 1H NMR (500 MHz, Acetone-d6) spectrum of compound 2 Figure S13. 13C NMR (125 MHz, Acetone-d6) spectrum of compound 2 Figure S14. DEPT 135 NMR (125 MHz, Acetone-d6) spectrum of compound 2 Figure S15. 1H–1H COSY (500 MHz, Acetone-d6) spectrum of compound 2 Figure S16. HSQC spectrum of compound 2 in Acetone-d6 Figure S17. HMBC spectrum of compound 2 in Acetone-d6 Figure S18. Key 1H–1H COSY and HMBC correlations of compound 2 Figure S19. Experimental and calculated electronic circular dichroism (ECD) spectra of compound 2 Figure S20. 1H NMR (500 MHz, Acetone-d6) spectrum of compound 3 Figure S21. 13C NMR (125 MHz, Acetone-d6) spectrum of compound 3 Figure S22. DEPT 135 NMR (125 MHz, Acetone-d6) spectrum of compound 3 Figure S23. 1H–1H COSY (500 MHz, Acetone-d6) spectrum of compound 3 Figure S24. HSQC spectrum of compound 3 in Acetone-d6 Figure S25. HMBC spectrum of compound 3 in Acetone-d6 Figure S26. NOESY spectrum of compound 3 in Acetone-d6 Figure S27. Key 1H–1H COSY, 1H–1H NOESY, and HMBC correlations of compound 3 Figure S28. Experimental and calculated electronic circular dichroism (ECD) spectra of compound 3 1. Table Lists Table S1 1H and 13C NMR spectroscopic data of compound 1 Position 1 a δH, mult. J (Hz) δC b 2ax 3.94 m 70.2 2eq 4.17 dddd (8.8, 6.8, 3.6, 2.1) 3 3.47 tdd (11.0, 5.3, 3.6) 31.3 4 2.80 m 31.5 2.91 m 5 6.90 dd (8.3, 4.0) 130.1 6 6.39 ddd (8.3, 2.5, 1.4) 107.9 7 8 157.7 6.31 dd (2.5, 1.5) 102.8 9 155.1 10 113.4 1′ 125.4 2′ 156.9 3′ 113.6 4′ 153.1 5′ 6.57 d (8.5) 112.9 6′ 7.00 dd (8.5, 1.5) 125.5 1″ 2″ 76.6 3″ 3.81 m 68.4 4″ax 2.71 ddd (17.2, 9.8, 7.8) 26.7 4″eq 3.05 dt (16.9, 6.0) 5″ 1.26 s 19.6 6″ 1.36 s 25.2 2′-OCH3 3.79 s 61.2 a (500 MHz, acetone-d6); b(125 MHz, acetone-d6) Table S2 1H and 13C NMR spectroscopic data of compound 2 Position 2 a δH, mult. J (Hz) δC b 2ax 3.92 t (10.5) 2eq 4.17 ddd (10.4, 3.6, 2.1) 3 3.46 ddd (11.0, 5.3, 3.5) 31.4 4ax 2.80 ddd (15.7, 5.4, 2.1) 31.8 4eq 2.89 ddd (15.7, 11.3, 1.1) 5 6.90 d (8.2) 130.2 6 6.39 dd (8.2, 2.5) 107.9 7 8 70.4 157.7 6.32 dd (2.5) 102.8 9 155.1 10 113.5 1′ 125.5 2′ 157.4 3′ 121.7 4′ 155.0 5′ 6.69 d (8.4) 111.4 6′ 6.93 d (8.4) 125.0 1″ 3.40 m 23.2 2″ 5.31 tsep (7.3, 1.5) 123.6 3″ 130.1 4″ 1.68 d (1.5) 24.9 5″ 1.79 d (1.3) 17.1 3.75 s 61.4 6″ 2′-OCH3 a (500 MHz, acetone-d6); b(125 MHz, acetone-d6) Table S3: 1H and 13C NMR spectroscopic data of compound 3 Position 3 a δH, mult. J (Hz) δC b 2 5.44 dd (13.1, 2.9) 79.7 3ax 2.68 ddd (16.7, 2.9, 1.5) 43.8 3eq 3.06 *dd (16.7, 13.1) 4 189.6 5 7.74 d (8.7) 128.6 6 6.59 dd (8.7, 2.3) 110.3 7 8 163.6 6.43 d (2.3) 102.8 9 164.5 10 114.3 1′ 2′ 128.5 * 7.28 m 128.3 3′ 120.5 4′ 153.4 5′ 6.79 m 116.7 6′ 7.28 m 125.8 1″ 2″ 68.9 3″ 3.83 dd (9.5, 5.6) 77.2 4″eq 3.06 *dd (16.7, 13.1) 31.3 4″ax 2.78 ddd (16.7, 7.9, 2.9) 5″ 1.27 s 19.9 6″ 1.37 s 26.1 a (500 MHz, acetone-d6); b(125 MHz, acetone-d6); *Overlapping signals Table S4. Antibacterial activities of compounds 1 – 4 (MIC, mg/mL). Bacterial strains Tested compounds 1 2 3 4 Streptomycin S. aures ATCC 25923 0.063 0.125 0.125 0.125 0.005 E. coli ATCC 25922 1.000 1.000 1.000 1.000 0.001 2. Figure Lists Figure S1. APCI-HRMS spectrum of compound 1 Figure S2. 1H NMR (500 MHz, Acetone-d6) spectrum of compound 1 Figure S3. 13C NMR (125 MHz, Acetone-d6) spectrum of compound 1 Figure S4. DEPT 135 NMR (125 MHz, Acetone-d6) spectrum of compound 1 Figure S5. 1H–1H COSY (500 MHz, Acetone-d6) spectrum of compound 1 Figure S6. HMQC spectrum of compound 1 in Acetone-d6 Figure S7. HMBC spectrum of compound 1 in Acetone-d6 Figure S8. NOESY spectrum of compound 1 in Acetone-d6 Figure S9. Key 1H–1H COSY and HMBC correlations of compound 1 Figure S10. Experimental and calculated electronic circular dichroism (ECD) spectra of compound 1 Figure S11. APCI-HRMS spectrum of compound 2 Figure S12. 1H NMR (500 MHz, Acetone-d6) spectrum of compound 2 Figure S13. 13C NMR (125 MHz, Acetone-d6) spectrum of compound 2 Figure S14. DEPT 135 NMR (125 MHz, Acetone-d6) spectrum of compound 2 Figure S15. 1H–1H COSY (500 MHz, Acetone-d6) spectrum of compound 2 Figure S16. HSQC spectrum of compound 2 in Acetone-d6 Figure S17. HMBC spectrum of compound 2 in Acetone-d6 Figure S18. Key 1H–1H COSY and HMBC correlations of compound 2 Figure S19. Experimental and calculated electronic circular dichroism (ECD) spectra of compound 2 Figure S20. 1H NMR (500 MHz, Acetone-d6) spectrum of compound 3 Figure S21. 13C NMR (125 MHz, Acetone-d6) spectrum of compound 3 Figure S22. DEPT 135 NMR (125 MHz, Acetone-d6) spectrum of compound 3 Figure S23. 1H–1H COSY (500 MHz, Acetone-d6) spectrum of compound 3 Figure S24. HSQC spectrum of compound 3 in Acetone-d6 Figure S25. HMBC spectrum of compound 3 in Acetone-d6 Figure S26. NOESY spectrum of compound 3 in Acetone-d6 Figure S27. Key 1H–1H COSY, 1H-1H NOESY, and HMBC correlations of compound 3 Figure S28. Experimental and calculated electronic circular dichroism (ECD) spectra of compound 3